Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting
Clinical trial NCT04840459 · UNKNOWN
Trial details
- NCT number
- NCT04840459
- Sponsor
- Sohail Rao
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-20
- Primary completion
- 2022-12-31
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.